Posts Tagged ‘Low molecular weight heparin’
Occasionally, a patient is treated with long-term low molecular weight heparin (LMWH) (enoxaparin = Lovenox®; Dalteparin = Fragmin®; Tinzaparin = Innohep®) . LMWH may be given because the patient (a) tolerated warfarin poorly (widely fluctuating INRs; significant side-effects, such as marked hair loss or fatigue), (b) had a recurrent thrombotic event which occured with a therapeutic INR, or (c) is pregnant and needs an anticoaglant because of an increased risk for thrombosis. The main side-effect of long-term LMWH is, of course, bleeding.
Whether LMWH cause osteoporosis is not known, Read the rest of this entry »